Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07655245Not yet recruiting
Randomised, double-blind trial of caffeine in hypotension (2 arms), sponsored by Cairo University. Primary endpoint: Average noradrenaline requirement. Planned start Jun 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07655245.